We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.6B
AUM Growth
+$4.82B
Cap. Flow
+$3.68B
Cap. Flow %
8.65%
Top 10 Hldgs %
12.95%
Holding
2,932
New
107
Increased
1,463
Reduced
1,212
Closed
134

Sector Composition

Rank Sector Weight
1 Technology 12.83%
2 Financials 12.17%
3 Healthcare 10.88%
4 Industrials 10.2%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGI
2576
DELISTED
Triumph Group
TGI
$252K ﹤0.01%
+8,464
New +$242K
KB icon
2577
KB Financial Group
KB
$42.2B
$249K ﹤0.01%
+5,083
New +$254K
AAMI
2578
Acadian Asset Management
AAMI
$3.2B
$247K ﹤0.01%
16,512
+452
+3% +$6.45K
PI icon
2579
Impinj
PI
$4.93B
$246K ﹤0.01%
5,911
-3,963
-40% -$167K
CSR
2580
Centerspace
CSR
$932M
$245K ﹤0.01%
4,020
-182
-4% -$11.2K
ALDR
2581
DELISTED
Alder Biopharmaceuticals
ALDR
$245K ﹤0.01%
19,973
-89,583
-82% -$934K
MNRO icon
2582
Monro
MNRO
$399M
$244K ﹤0.01%
+4,373
New +$205K
FIT
2583
DELISTED
Fitbit, Inc. Class A common stock
FIT
$244K ﹤0.01%
34,938
-7,366
-17% -$42.9K
CVRR
2584
DELISTED
CVR Refining, LP
CVRR
$244K ﹤0.01%
24,800
-7,579
-23% -$64.1K
VRNS icon
2585
Varonis Systems
VRNS
$4.73B
$241K ﹤0.01%
17,214
-1,302
-7% -$16.8K
WIN
2586
DELISTED
Windstream Holdings Inc
WIN
$241K ﹤0.01%
27,399
-8,085
-23% -$107K
INGN icon
2587
Inogen
INGN
$182M
$236K ﹤0.01%
2,474
-315
-11% -$30.4K
PDLI
2588
DELISTED
PDL BioPharma, Inc.
PDLI
$234K ﹤0.01%
69,050
-11,043
-14% -$30.7K
VIA
2589
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$232K ﹤0.01%
+3,099
New +$278K
EDU icon
2590
New Oriental
EDU
$9.4B
$230K ﹤0.01%
+2,602
New +$212K
SID icon
2591
Companhia Siderúrgica Nacional
SID
$1.23B
$230K ﹤0.01%
77,792
-21,600
-22% -$58K
JONE
2592
DELISTED
Jones Energy, Inc.
JONE
$230K ﹤0.01%
6,034
+5
+0.1% +$133
WSR
2593
DELISTED
Whitestone REIT
WSR
$229K ﹤0.01%
17,479
+897
+5% +$11.5K
ATH
2594
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$229K ﹤0.01%
+4,264
New +$221K
GSH
2595
DELISTED
Guangshen Railway Co. Ltd
GSH
$229K ﹤0.01%
+7,851
New +$210K
NXTM
2596
DELISTED
NxStage Medical Inc.
NXTM
$228K ﹤0.01%
+8,298
New +$221K
CHRS icon
2597
Coherus Oncology
CHRS
$222M
$227K ﹤0.01%
16,980
+2,366
+16% +$31.3K
TEAM icon
2598
Atlassian
TEAM
$26.3B
$227K ﹤0.01%
+6,449
New +$229K
BBOX
2599
DELISTED
Black Box Corp
BBOX
$226K ﹤0.01%
69,742
+19,408
+39% +$104K
IMAX icon
2600
IMAX
IMAX
$2.8B
$225K ﹤0.01%
9,897
-8,453
-46% -$174K

Similar funds

Guggenheim Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Guggenheim Capital held 2,932 positions worth $42.6B, up 13% from $37.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital deployed $3.68B of net new capital in Q3 2017, opening 107 new positions and adding to 1,463 existing holdings. Its largest new stake was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $46.6M trimmed.

  • Guggenheim Capital's largest Q3 2017 buy was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.
  • Guggenheim Capital added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2017, an estimated $209M increase.
  • Guggenheim Capital's biggest Q3 2017 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $46.6M.
  • Guggenheim Capital fully exited Reynolds American Inc in Q3 2017, selling an estimated $68.3M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $42.6B portfolio in Q3 2017.
  • Guggenheim Capital opened 107 new positions and closed 134 in Q3 2017.
  • Guggenheim Capital's portfolio value rose 13% quarter-over-quarter to $42.6B.

Based on Guggenheim Capital's 13F filing for Q3 2017, filed 14 Nov 2017.